Moss Introduces Diet and Vitamin Reports
Moss Introduces Diet and Vitamin Reports
"Our new diet and vitamin reports give customers 16 different reports based on their genetic information with up to 80 million genetic variants being analyzed."Vancouver, British Columbia--(Newsfile Corp. - June 16, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia announces the introduction of its diet and vitamin reports (the "Reports") which can be ordered directly to your home via our online platform.
溫哥華，不列顛哥倫比亞省-(Newsfile Corp.-2023年6月16日)-Moss Genology Inc.(CSE：MOSS)(“苔蘚“或”公司)，一家位於不列顛哥倫比亞省溫哥華的消費者基因組和腸道微生物組公司宣佈推出其飲食和維生素報告(The報告“)可通過我們的在線平臺直接訂購到您的家中。
Up to 80 million genetic variants are analyzed to provide the most insightful information concerning dietary needs and vitamin deficiencies. Our diet reports provide information about celiac, alcohol sensitivity, sweet tooth, caffeine related anxiety, hunger, food allergies, response to carbohydrates, bitter taste sensitivity and lactose intolerance. Our Reports highlight micronutrient deficiencies and requirements such as Riboflavin, MTHFR (folate), Vitamin B12, Vitamin C, Vitamin D and Iron. These Reports give customers the opportunity to further explore and understand their genetic data. Moss customers can enjoy a comprehensive suite of genetic reports available in our online shop.
多達8000萬個基因變異被分析，以提供關於飲食需求和維生素缺乏的最有洞察力的資訊。我們的飲食報告提供有關乳糜瀉、酒精敏感、愛吃甜食、咖啡因相關的焦慮、飢餓、食物過敏、對碳水化合物的反應、苦味敏感和乳糖不耐受等資訊。我們的報告強調了微量營養素的缺乏和需求，如核黃素、MTHFR(葉酸)、維生素B12、維生素C、維生素D和鐵。這些報告為客戶提供了進一步探索和了解他們的基因數據的機會。MOSS客戶可以在我們的網上商店享受到一套全面的基因報告。
"Moss' goal is to empower customers with the tools to understand their own biology and environmental factors which influence their health. The customer is presented with an action plan to meet their physical and mental health goals," said Karl Cahill, CEO of the Company.
該公司首席執行官卡爾·卡希爾表示：“Moss的目標是讓客戶有能力瞭解影響他們健康的生物和環境因素。我們為客戶提供了一份行動計劃，以實現他們的身心健康目標。”
"Our new diet and vitamin reports give customers 16 different reports based on their genetic information with up to 80 million genetic variants being analyzed."
我們新的飲食和維生素報告根據顧客的遺傳資訊向他們提供了16種不同的報告，分析了多達8000萬種遺傳變異。
Moss has created an online healthcare and technology platform integrating labs, services, and products in a shared economy. Moss provides comprehensive and affordable, at-home genetic and microbiome testing paired with personalized wellness reports and offerings to promote total gut, mind, and body health. The Company's services include health reports, personalized food and nutrition recommendations, and a social media platform that allows customers to form communities based on their specific health needs. The Company's current and anticipated products can be found in the "Shop" section of its website.
MOSS創建了一個在線醫療和技術平臺，將實驗室、服務和產品整合到共享經濟中。MOSS提供全面且負擔得起的家庭遺傳和微生物組檢測，並配以個性化的健康報告和產品，以促進腸道、精神和身體的全面健康。該公司的服務包括健康報告、個性化食品和營養建議，以及允許客戶根據其特定健康需求組建社區的社交媒體平臺。該公司當前和預期的產品可在其網站的“商店”部分找到。
For further information concerning Moss and its business, please view the Company's long form prospectus dated December 13, 2022 (the "Prospectus") and CSE listing statement dated January 16, 2023 (the "Listing Statement") supporting Moss's listing on the CSE, as well as the Company's website at . Copies of the Prospectus and Listing Statement are available on the Company's SEDAR profile at .
欲瞭解更多關於MOSS及其業務的資訊，請參閱本公司日期為2022年12月13日的詳細招股說明書(“招股說明書)及於2023年1月16日發出的中交所上市聲明(“上市聲明“)支持MOSS在CSE上市，以及本公司網站。招股說明書和上市說明書的副本可在公司SEDAR簡介中查閱。
About Moss Genomics Inc.
Moss Genomics Inc. is an emerging consumer genomics company that offers personalized health, anti-aging and wellness offerings guided by genomic, microbiome, and epigenome data. The Company intends to eliminate barriers in healthcare by offering easy-access, at-home, affordable testing paired with easy-to-understand actionable results.
關於莫斯基因公司
莫斯基因組公司是一家新興的消費者基因組學公司，提供以基因組、微生物組和表觀基因組數據為指導的個性化健康、抗衰老和健康產品。該公司打算通過提供易於獲取、在家中、負擔得起的測試以及易於理解的可行結果來消除醫療保健方面的障礙。
For further information, please contact:
Karl Cahill
Chief Executive Officer and Director
如需更多資訊，請聯繫：
卡爾·卡希爾
董事首席執行官兼首席執行官
Michelle Lee
President
Email: info@mossgenomics.com
Telephone: 604-629-5974
李嘉欣
總裁
電子郵件：info@mossgenomics.com
電話：604-629-5974
TikTok: GutHealthTok | Instagram: MossGenomics | LinkedIn: MossGenomics
TikTok：GutHealthTok|Instagram：MossGenology|LinkedIn：MossGenology
The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
CSE既沒有批准也沒有不批准本新聞稿的內容。CSE及其市場監管機構(該術語在CSE的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Cautionary Note Regarding Forward-Looking Information
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation, including with respect to anticipated product offerings and the objectives and development of the Company. Forward-looking statements are necessarily based upon several estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties, and uncertain capital markets. Readers are cautioned that actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
關於前瞻性資訊的注意事項
根據適用的加拿大證券法，本新聞稿包括某些“前瞻性陳述”，包括與預期的產品供應以及公司的目標和發展有關的陳述。前瞻性陳述必須基於若干估計和假設，雖然這些估計和假設被認為是合理的，但可能會受到已知和未知的風險、不確定性和其他因素的影響，這些因素可能會導致實際結果和未來事件與此類前瞻性陳述明示或暗示的內容大不相同。這些因素包括但不限於一般商業、經濟、競爭、政治和社會不確定性，以及不確定的資本市場。提醒讀者，實際結果和未來事件可能與此類聲明中預期的大不相同。因此，讀者不應過分依賴前瞻性陳述。除非法律要求，否則公司不會因為新資訊、未來事件或其他原因而更新或修改任何前瞻性陳述，也不承擔任何義務。
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。
